10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 322 filers reported holding 10X GENOMICS INC in Q1 2021. The put-call ratio across all filers is 1.39 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $262,804 | -27.2% | 6,371 | -1.4% | 0.01% | -25.0% |
| Q2 2023 | $360,894 | -3.7% | 6,463 | -3.8% | 0.01% | -25.0% |
| Q1 2023 | $374,630 | +53.1% | 6,715 | 0.0% | 0.02% | +33.3% |
| Q4 2022 | $244,695 | -24.0% | 6,715 | +58.6% | 0.01% | 0.0% |
| Q1 2022 | $322,000 | -43.2% | 4,234 | +11.2% | 0.01% | -36.8% |
| Q4 2021 | $567,000 | +16.7% | 3,806 | +14.0% | 0.02% | +5.6% |
| Q3 2021 | $486,000 | -31.9% | 3,339 | -8.5% | 0.02% | -28.0% |
| Q2 2021 | $714,000 | +88.4% | 3,648 | +74.4% | 0.02% | +66.7% |
| Q1 2021 | $379,000 | – | 2,092 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,358,528 | $49,504,760 | 100.00% |
| Meritech Capital Associates V L.L.C. | 1,061,682 | $38,687,692 | 9.44% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $13,102,148 | 4.90% |
| Sands Capital Ventures, LLC | 481,770 | $17,556 | 4.81% |
| Whitford Management LLC | 58,310 | $2,124,803 | 2.88% |
| FINANCIAL CONSULATE, INC | 156,457 | $5,701,293 | 1.99% |
| SRS Investment Management, LLC | 3,005,427 | $109,517,760 | 1.98% |
| BRANDYWINE MANAGERS, LLC | 11,208 | $408,420 | 1.43% |
| ARK Investment Management | 4,316,567 | $157,295,701 | 1.36% |
| Nikko Asset Management Americas, Inc. | 2,177,988 | $79,365,883 | 1.14% |